FDA Approves First Ever Nasal Testosterone Treatment
Testosterone treatments are a means of supplementing low testosterone (Low T) levels. Men suffer from Low T for a number of reasons ranging from age to various medical afflictions. The common methods of dosing all have their cons. A doctor can give injections once or twice a week, but that is very inconvenient for the patient. Patches, gels, and solutions are all better choices for convenience’s sake, but contact with the product or treated area by women and children can have adverse affects on their hormone levels. That is why the approval of Natesto, the first nasal testosterone treatment, is significant for patients with Low T levels. Natesto has been approved to treat the absence of or reduced levels of endogenous testosterone.
The Benefits Of Natesto
The obvious benefit of Natesto is the delivery system. The nasal testosterone treatment uses a metered-dose pump mechanism to deliver the dosage. The delivery minimizes the chance for women and children to suffer from elevated testosterone levels due to contact with the patient. It is also far more convenient for the patient than needing to visit their doctor for regular, painful injections. The intranasal gel still works through absorption but is taken in through the nasal lining.
The Potential Cons Of Nasal Testosterone Treatment
At present, there is really only one notable downside to using a nasal testosterone treatment, not including its possible side effects. The actuator of the sprayer is designed to dose 5.5 mg of the gel. The recommend dose is 11mg, or a shot up each nostril. The recommended daily dose is 33mg. It is unclear how well men will be able to keep up with dosing themselves three times a day or what the exact effects will be if the patient has a runny nose from sickness or seasonal allergies.
On the theoretical side of things, there are other concerns. One doctor wondered if nasal testosterone treatment dosing may result in increased testosterone levels in the brain. A 2009 study showed that mice that received nasal testosterone treatments had twice the level of brain testosterone as the control group. Whether or not this will apply to humans is unknown.
The biggest concern with nasal testosterone treatment is its newness. Nasal testosterone treatment has been subject to trials to help determine safety, but we often see other problems develop once a treatment is available to the general population. There are an estimated 13 million Americans with Low T that could benefit from treatment. That is a lot of incentive for companies like Trimel Pharmaceuticals Corporation to develop new, more convenient methods of dosing.
Long-term heavyweights like AndroGel resulted in many lawsuits due to under-reported chances of serious side effects like heart attacks or strokes. Some patients suffered from serious complications if they also had heart, kidney, or lung disease. AbbVie Inc, the maker of AndroGel, was accused of downplaying the severity of these risks. It is not unreasonable to think Natesto consumers might fear the same risks.
Seeking Legal Counsel For Low T Treatment Complications
If you or a loved one has experienced complications believed to be related to Low T treatments, contact the American Injury Attorney Group today for a free, no-obligation consultation. We can inform you of your legal rights and, if you have a claim, we can connect you with an affiliated attorney who can fight for those rights and help you seek the compensation to which you may be entitled.